Justine Rudner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Protein Protein

Acute Respiratory Distress Syndrome

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Sophia A Hogh-Binder, Diana Klein, Frederik Wolfsperger, Stephan M Huber, Jörg Hennenlotter, Arnulf Stenzl, Justine Rudner
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy. Cancers 15 (9) (2023)
Sophia A Hogh-Binder, Diana Klein, Frederik Wolfsperger, Stephan M Huber, Jörg Hennenlotter, Arnulf Stenzl, Justine Rudner
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy. Cancers 15 (9) (2023)
Violetta Ritter, Franziska Krautter, Diana Klein, Verena Jendrossek, Justine Rudner
Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy. Cell death & disease 13 (4) (2022)
Violetta Ritter, Franziska Krautter, Diana Klein, Verena Jendrossek, Justine Rudner
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy. Cell death & disease 12 (7) (2021)